OA
BIIB icon

OFI Advisors’s Biogen BIIB Stock Holding History

OFI Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$801K Buy
2,746
+411
+18% +$136K 0.05% 453
2015
Q2 		$943K Buy
2,335
+338
+17% +$136K 0.06% 424
2015
Q1 		$843K Sell
1,997
-154
-7% -$60.7K 0.05% 460
2014
Q4 		$730K Buy
2,151
+159
+8% +$51.4K 0.05% 484
2014
Q3 		$659K Buy
1,992
+132
+7% +$43.5K 0.05% 479
2014
Q2 		$586K Buy
1,860
+441
+31% +$133K 0.04% 550
2014
Q1 		$434K Sell
1,419
-152
-10% -$48.3K 0.03% 662
2013
Q4 		$439K Buy
1,571
+77
+5% +$19.9K 0.04% 623
2013
Q3 		$360K Sell
1,494
-164
-10% -$36.7K 0.03% 615
2013
Q2 		$357K Buy
+1,658
New +$354K 0.04% 545

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

OFI Advisors's BIIB Position: Q3 2015 in Review

OFI Advisors increased its Biogen (BIIB) stake by 18% in Q3 2015, buying an estimated $136K and bringing the position to 2,746 shares worth $801K. The position accounts for 0.05% of the portfolio, ranked #453.

OFI Advisors first reported a position in BIIB in Q2 2013 and has held it in 10 quarters since. The position peaked at $943K in Q2 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • OFI Advisors held 2,746 shares of Biogen worth $801K as of Q3 2015.
  • OFI Advisors bought 411 Biogen shares in Q3 2015, an estimated $136K.
  • Biogen made up 0.05% of OFI Advisors's portfolio in Q3 2015, its #453 holding.
  • OFI Advisors first reported a position in Biogen in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Biogen position peaked at $943K in Q2 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.